Otsuka, Lundbeck files NDA for schizophrenia drug

Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...

July 15, 2014 | Tuesday | News
HealthPatch MD receives Japanese nod

Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in th...

February 19, 2015 | Thursday | News
Amgen-Cytokinetics collaboration to include Japan

Singapore: USA-based Amgen, the world's largest independent biotech company, has expanded its strategic collaboration wi...

June 17, 2013 | Monday | News
Taiho seeks Japanese nod for oral cancer agent

Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral...

February 28, 2013 | Thursday | News
FDA approves Eisai's Fycompa

Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration ...

April 24, 2012 | Tuesday | News
Innovative dual chamber syringe for pharma market

Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new typ...

June 5, 2012 | Tuesday | News
Takeda to acquire LigoCyte Pharma

Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned s...

April 24, 2012 | Tuesday | News
BioJapan to kick off in October

Singapore: The 17th edition of BioJapan is all set to kick off from October 14, 2015 Pacifico Yokohama. Top industry pla...

April 24, 2012 | Tuesday | News
Takeda, Resolve to develop, sell autoimmune drugs

Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the t...

February 28, 2013 | Thursday | News
Takeda acquires LigoCyte Pharmaceuticals at $60 mn

Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...

April 24, 2012 | Tuesday | News
GlobalData: Osteoporosis market to be $8 bn

Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, th...

March 8, 2013 | Friday | Analysis
R-Tech Ueno loses case against Takeda

Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in t...

July 9, 2012 | Monday | News
APAC ovarian cancer drug market to grow modestly'

Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...

January 30, 2015 | Friday | Analysis
Agenix gets patent for ThromboView in Japan

Singapore: Japan's Patent Office has granted a key patent to drug and diagnostic company Agenix covering the manufacturi...

April 24, 2012 | Tuesday | Regulatory
Deal with Janssen gets Astellas $65 million up-front

Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...

October 2, 2012 | Tuesday | News
Scil Proteins, Ono collaborate to develop Affilin therapeutics

Singapore: Scil Proteins, a private biotech company specializing in the research, development and production of recombin...

April 24, 2012 | Tuesday | News
Takeda acquires URL Pharma

Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings...

June 8, 2012 | Friday | News
Lorcaserin receives positive vote from FDA advisory committee

Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory...

April 24, 2012 | Tuesday | News
Genetic diagnostics companies speed ahead

The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US...

June 28, 2013 | Friday | Opinion
Amgen CEO speaks of firm's grand entry into Japan

The world's largest biotechnology company Amgen entered into a long-term collaboration with Astellas Pharma in May this ...

June 13, 2013 | Thursday | News